Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Term ID:11451
Name:Usher syndrome, type 2C
Definition:
Alternative IDs:OMIM:605472
ParentIDs:MESH:D052245
TreeNumbers:C09.218.458.341.186.500.500/C536492 |C09.218.458.341.887.886/C536492 |C10.597.751.418.341.186.500.500/C536492 |C10.597.751.418.341.887.886/C536492 |C10.597.751.941.162.625.500/C536492 |C11.768.585.658.500.813/C536492 |C11.966.075.375.500/C536492 |C16.131.077.29
Synonyms:USH2C |USHER SYNDROME, TYPE IIB, FORMERLY, INCLUDED;USH2B, FORMERLY, INCLUDED |Usher Syndrome, Type IIC |USHER SYNDROME, TYPE IIC, GPR98/PDZD7, DIGENIC, INCLUDED
Slim Mappings:Congenital abnormality|Ear-nose-throat disease|Eye disease|Genetic disease (inborn)|Nervous system disease|Signs and symptoms
Reference: MedGen: C536492
MeSH: C536492
OMIM: 605472;

Genes: ADGRV1; PDZD7;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0008527Congenital sensorineural hearing impairment
3 HP:0000510Rod-cone dystrophy
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_032119.3(ADGRV1):c.1239-8C>G84059ADGRV1Likely pathogenic869312178RCV000210295; NMedGen:C1854237,OMIM:60547258992437189924371NM_032119.3:c.1239-8C>GNC_000005.9:g.89924371C>G-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.1701delC (p.Leu568Cysfs)84059ADGRV1Pathogenic-1RCV000221685; NMedGen:C1854237,OMIM:60547258992521889925218NM_032119.3:c.1701delCNP_115495.3:p.Leu568Cysfs-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.2258_2270delAAGTGCTGAAATC (p.Gln753Leufs)84059ADGRV1Pathogenic796051866RCV000007206; NMedGen:C1854237,OMIM:60547258993847089938482NM_032119.3:c.2258_2270delAAGTGCTGAAATCNP_115495.3:p.Gln753LeufsNC_000005.9:g.89938470_89938482delAAGTGCTGAAATCOMIM Allelic Variant:602851.0008C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.2398C>T (p.Arg800Ter)84059ADGRV1Pathogenic373780305RCV000039562; NMedGen:C1854237,OMIM:60547258993870389938703NM_032119.3:c.2398C>TNP_115495.3:p.Arg800TerNC_000005.9:g.89938703C>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.2870dupA (p.Asn957Lysfs)84059ADGRV1Pathogenic397517429RCV000039565; NMedGen:C1854237,OMIM:60547258994065889940658NM_032119.3:c.2870dupANP_115495.3:p.Asn957LysfsNC_000005.9:g.89940658dupA-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.(?_4379)_(4752_?)del (p.(?))84059ADGRV1Pathogenic-1RCV000156303; NMedGen:C1854237,OMIM:60547258995372289954095NM_032119.3:c.(?_4379)_(4752_?)delNP_115495.3:p.(?)-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.4702delA (p.Ser1568Valfs)84059ADGRV1Pathogenic794727347RCV000176234; NMedGen:C1854237,OMIM:60547258995404589954045NM_032119.3:c.4702delANP_115495.3:p.Ser1568ValfsNC_000005.9:g.89954045delA-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.5357_5358delAA (p.Lys1786Ilefs)84059ADGRV1Pathogenic796051867RCV000007207; NMedGen:C1854237,OMIM:60547258997194089971941NM_032119.3:c.5357_5358delAANP_115495.3:p.Lys1786IlefsNC_000005.9:g.89971940_89971941delAAOMIM Allelic Variant:602851.0009C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.5643delG (p.Tyr1882Ilefs)84059ADGRV1Pathogenic727503076RCV000150761; NMedGen:C1854237,OMIM:60547258997725089977250NM_032119.3:c.5643delGNP_115495.3:p.Tyr1882IlefsNC_000005.9:g.89977250delG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.5779_5783dupACGAG (p.Ser1928Argfs)84059ADGRV1Pathogenic730880369RCV000156744; NMedGen:C1854237,OMIM:60547258997951789979521NM_032119.3:c.5779_5783dupACGAGNP_115495.3:p.Ser1928ArgfsNC_000005.9:g.89979517_89979521dupACGAG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.6901C>T (p.Gln2301Ter)84059ADGRV1Pathogenic121909762RCV000007200; NMedGen:C1854237,OMIM:60547258998680889986808NM_032119.3:c.6901C>TNP_115495.3:p.Gln2301TerNC_000005.9:g.89986808C>TOMIM Allelic Variant:602851.0002C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.7006C>T (p.Arg2336Ter)84059ADGRV1Likely pathogenic527236133RCV000132687; NMedGen:C1854237,OMIM:60547258998847689988476NM_032119.3:c.7006C>TNP_115495.3:p.Arg2336TerNC_000005.9:g.89988476C>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.7129C>T (p.Arg2377Ter)84059ADGRV1Pathogenic758718347RCV000214702; NMedGen:C1854237,OMIM:60547258998859989988599NM_032119.3:c.7129C>TNP_115495.3:p.Arg2377TerNC_000005.9:g.89988599C>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.7374_7375delTG (p.Glu2459Glyfs)84059ADGRV1Pathogenic397517435RCV000039626; NMedGen:C1854237,OMIM:60547258998994789989948NM_032119.3:c.7374_7375delTGNP_115495.3:p.Glu2459GlyfsNC_000005.9:g.89989947_89989948delTG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.7406G>A (p.Trp2469Ter)84059ADGRV1Pathogenic397517436RCV000039627; NMedGen:C1854237,OMIM:60547258998997989989979NM_032119.3:c.7406G>ANP_115495.3:p.Trp2469TerNC_000005.9:g.89989979G>A-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.8204delA (p.Asn2735Metfs)84059ADGRV1Pathogenic794727584RCV000177853; NMedGen:C1854237,OMIM:60547258999953089999530NM_032119.3:c.8204delANP_115495.3:p.Asn2735MetfsNC_000005.9:g.89999530delA-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.8713_8716dupAACA (p.Ile2906Lysfs)84059ADGRV1Pathogenic796051863RCV000007201; NMedGen:C1854237,OMIM:60547259000219490002197NM_032119.3:c.8713_8716dupAACANP_115495.3:p.Ile2906LysfsNC_000005.9:g.90002194_90002197dupAACAOMIM Allelic Variant:602851.0003C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.8737delG (p.Val2913Tyrfs)84059ADGRV1Pathogenic397517441RCV000039655; NMedGen:C1854237,OMIM:60547259000463990004639NM_032119.3:c.8737delGNP_115495.3:p.Val2913TyrfsNC_000005.9:g.90004639delG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.8790delC (p.Met2931Trpfs)84059ADGRV1Pathogenic796051864RCV000007202; NMedGen:C1854237,OMIM:60547259000469290004692NM_032119.3:c.8790delCNP_115495.3:p.Met2931TrpfsNC_000005.9:g.90004692delCOMIM Allelic Variant:602851.0004C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.10060_10063delACAA (p.Thr3354Serfs)84059ADGRV1Pathogenic727504978RCV000156391; NMedGen:C1854237,OMIM:60547259002137290021375NM_032119.3:c.10060_10063delACAANP_115495.3:p.Thr3354SerfsNC_000005.9:g.90021372_90021375delACAA-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.10229_10231dupTGG (p.Val3410_Ala3411insVal)84059ADGRV1Likely pathogenic397517418RCV000039501; NMedGen:C1854237,OMIM:60547259002455390024555NM_032119.3:c.10229_10231dupTGGNP_115495.3:p.Val3410_Ala3411insValNC_000005.9:g.90024553_90024555dupTGG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.11253C>G (p.Tyr3751Ter)84059ADGRV1Pathogenic376689763RCV000039510; NMedGen:C1854237,OMIM:60547259004952290049522NM_032119.3:c.11253C>GNP_115495.3:p.Tyr3751TerNC_000005.9:g.90049522C>G-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.12101T>G (p.Phe4034Cys)84059ADGRV1Likely pathogenic-1RCV000221151; NMedGen:C1854237,OMIM:60547259005538690055386NM_032119.3:c.12101T>GNP_115495.3:p.Phe4034Cys-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.12403+1G>T84059ADGRV1Likely pathogenic527236132RCV000132685; NMedGen:C1854237,OMIM:60547259007012190070121NM_032119.3:c.12403+1G>TNC_000005.9:g.90070121G>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.12631C>T (p.Arg4211Ter)84059ADGRV1Pathogenic727504777RCV000156094; NMedGen:C1854237,OMIM:60547259007382590073825NM_032119.3:c.12631C>TNP_115495.3:p.Arg4211TerNC_000005.9:g.90073825C>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.14885G>A (p.Trp4962Ter)84059ADGRV1Pathogenic-1RCV000217974; NMedGen:C1854237,OMIM:60547259010346790103467NM_032119.3:c.14885G>ANP_115495.3:p.Trp4962Ter-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.14973-2A>G84059ADGRV1Pathogenic371981035RCV000039531; NMedGen:C1854237,OMIM:60547259010604890106048NM_032119.3:c.14973-2A>GNC_000005.9:g.90106048A>G-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.15736C>T (p.Arg5246Ter)84059ADGRV1Likely pathogenic527236131RCV000132686; NMedGen:C1854237,OMIM:60547259010681390106813NM_032119.3:c.15736C>TNP_115495.3:p.Arg5246TerNC_000005.9:g.90106813C>T-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.17303_17315delGAGATTACATTCG (p.Gly5768Glufs)84059ADGRV1Pathogenic727504644RCV000155906; NMedGen:C1854237,OMIM:60547259014919990149211NM_032119.3:c.17303_17315delGAGATTACATTCGNP_115495.3:p.Gly5768GlufsNC_000005.9:g.90149199_90149211delGAGATTACATTCG-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.17662delT (p.Ser5888Hisfs)84059ADGRV1Pathogenic397517426RCV000039548; NMedGen:C1854237,OMIM:60547259015162590151625NM_032119.3:c.17662delTNP_115495.3:p.Ser5888HisfsNC_000005.9:g.90151625delT-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.18131A>G (p.Tyr6044Cys)84059ADGRV1Pathogenic121909763RCV000007204; NMedGen:C1854237,OMIM:60547259028131890281318NM_032119.3:c.18131A>GNP_115495.3:p.Tyr6044CysNC_000005.9:g.90281318A>GOMIM Allelic Variant:602851.0006C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.(?_18153)-15_*(15_?)del84059ADGRV1Pathogenic-1RCV000155450; NMedGen:C1854237,OMIM:60547259036824990459732NM_032119.3:c.(?_18153)-15_*(15_?)del-C1854237 605472 Usher syndrome, type 2C
NM_032119.3(ADGRV1):c.18732_18750del19 (p.Tyr6244Terfs)84059ADGRV1Pathogenic796051865RCV000007203; NMedGen:C1854237,OMIM:60547259044914590449163NM_032119.3:c.18732_18750del19NP_115495.3:p.Tyr6244TerfsNC_000005.9:g.90449145_90449163del19OMIM Allelic Variant:602851.0005C1854237 605472 Usher syndrome, type 2C